Navigation Links
BioCryst Clarifies Government Declaration Regarding Peramivir
Date:10/2/2009

BIRMINGHAM, Ala., Oct. 2 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Office of the Secretary, Department of Health & Human Services (HHS) has issued "HHS Secretary's Declaration for the Use of the Public Readiness and Emergency Preparedness Act for the Influenza Antiviral Peramivir." Notice of this Declaration was posted today in the Federal Register and can be found on the Web at:

http://www.thefederalregister.com/d.p/2009-10-02-E9-23761

This Declaration represents a required step before an Emergency Use Authorization (EUA) may be issued. Further information regarding the EUA process may be found in a policy review available from the U.S. Centers for Disease Control (CDC) and can be found on the Web at:

http://www.cdc.gov/eid/content/13/7/1046.htm

About peramivir

Peramivir is an anti-viral agent that was discovered by BioCryst which inhibits the interactions of influenza neuraminidase, an enzyme which is critical to the spread of influenza within a host. In laboratory tests, peramivir has shown activity against pandemic H1N1 swine flu origin viral strains. Peramivir has been studied in patients with complicated and uncomplicated influenza. BioCryst's partner, Shionogi & Co., Ltd. is currently preparing to file for regulatory approval in Japan this year.

About BioCryst

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer and inflammatory diseases. BioCryst has progressed two novel compounds into late-stage pivotal clinical trials; peramivir, an anti-viral for infl
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioCryst Provides Update Regarding Peramivir for Influenza
2. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
3. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
4. BioCryst Pharmaceuticals to Announce Peramivir Update and First Quarter 2009 Financial Results on May 8, 2009
5. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
6. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
7. BioCryst Updates Peramivir Clinical Development Plan
8. BioCryst Provides Forodesine HCl Update
9. BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
10. Mayo Clinic Clarifies Diagnosis and Treatment for Rare, Serious Blood Vessel Disease of Brain and Spinal Cord
11. Southern Research to Play Key Role in the Federal Governments Search for New Cancer Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014  Decision Resources Group,s experts are ... the Affordable Care Act (ACA), which has ... therapies. The ACA altered how Managed Care ... and expanded access via government-supported programs. Dynamic ... marketplaces set up by states or the ...
(Date:7/31/2014)... -- Hovione today announced that its API plant ... a pre-approval inspection by the US Food and Drug Administration ... Consumer Safety Officer, Ms. Britanny Terhar , lasted 5 ... and concluded on the 25 th . The inspection confirmed ... of Good Manufacturing Practices (GMP) and no Form 483 observations ...
(Date:7/31/2014)... 2014  Zacks.com announces the list of stocks featured in ... discuss the latest news and events impacting stocks and the ... (Nasdaq: BIIB - Free Report ), Gilead (Nasdaq: ... - Free Report ), AbbVie (NYSE: ABBV - Free ... ). Today, Zacks is promoting its ,Buy, stock ...
Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6
(Date:7/31/2014)... NEWwoodworks, fine woodworking group at New Energy ... a website dedicated to highlighting their craft and their ... handcrafted cabinetry, furniture, stairs , doors, and other ... for taking on the remarkable, challenging projects that few ... reclaimed wood, often using near extinct species such as ...
(Date:7/31/2014)... 31, 2014 Dr. Mohebi was asked ... love the experience of traveling and sharing what we ... Southern California. We are now witnessing results that ... It is our pleasure to communicate this knowledge to ... efficient ways of performing FUE transplantation helped inspire many ...
(Date:7/31/2014)... Andrie, Inc. V. Dept. of Treasury, Mich. ... Court has made the determination that a purchaser of tangible ... taxpayer was unable to prove during an audit that ... the Court of Appeals decision on whether a purchaser bears ... for purchases from Michigan sellers. The Court states “in order ...
(Date:7/31/2014)... NY (PRWEB) July 31, 2014 Located on ... street from Macy’s, The Rothenberg Law Firm LLP has moved ... Seventh Avenue. , The Rothenberg Law Firm has been handling ... has been spurred by growth in the firm’s continued success ... The firm’s New York office has a team of experienced ...
(Date:7/31/2014)... 31, 2014 Two years in the ... in-depth overview of the research behind the latest scientific ... Davis and Vesanto Melina, well-respected authorities on plant-based nutrition, ... are safe and adequate for people at all stages ... as athletes and pregnant or lactating women. , ...
Breaking Medicine News(10 mins):Health News:NEWwoodworks Fine Woodworking Group Launches New Website 2Health News:NEWwoodworks Fine Woodworking Group Launches New Website 3Health News:Los Angles Hair Transplant Surgeon, Dr. Parsa Mohebi Inspires Doctors at Global Conferences to Adopt His Novel Method in FUE Hair Transplantation 2Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 2Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 3Health News:New Book Presents Health Professionals With A Fully-Referenced, Meticulous Overview of the Research on Plant-Based Diets As A Healthy Choice 2Health News:New Book Presents Health Professionals With A Fully-Referenced, Meticulous Overview of the Research on Plant-Based Diets As A Healthy Choice 3
... LaVoie Group, a full-service,provider of public relations, ... science clients, today announced that it has,been selected ... therapeutics,company, Neotropix(R), Inc., Donna L. LaVoie, President ... to represent Neotropix during an important stage in ...
... dental clinic of Dr. Michael McCarty, is now offering ... is the answer for those who need dental work ... procedures have made it safe and comfortable for people ... memories of a painful experience. Dr. Michael McCarty from ...
... A protein required for the earliest steps in embryonic development ... the brains of adult animals, scientists have revealed. An ... beta-catenin could be a potential target for drugs to enhance ... are published online this week and appear in the October ...
... MATEO, Calif., Sept. 27 In order to ... of Labor Ray Marshall, the outside,hearing officer in ... announced that he will be issuing a notice ... were unable to,conclude their presentations over the original ...
... allergy and asthma problems after Hurricane Ike and provides helpful tips ... ... TX (PRWEB) September 24, 2008--Although Hurricane Ike has already wreaked havoc ... devastating hurricane has yet to be determined. It may be ...
... Whole Health Educators Form Army in the Battle Against Chronic Disease ... ... -- Can overeating be a symptom of negative emotions? Could a ... diet or anxiety? Yes, says an international organization whose uniquely trained ...
Cached Medicine News:Health News:LaVoie Group Adds Cancer Therapeutics Company, Neotropix(R),to Its Life Science Agency Roster 2Health News:Austin Dentistry Clinic Now Offers Certified Full Service Sedation Dentistry -- All Gain, No Pain 2Health News:'Hub' of fear memory formation identified in brain cells 2Health News:'Hub' of fear memory formation identified in brain cells 3Health News:Hearing Officer Secretary Ray Marshall to Set Additional Date(s) for United Healthcare Workers-West Trusteeship Hearing 2Health News:Sudden Rise in Allergies and Asthma After Hurricane Ike 2Health News:Sudden Rise in Allergies and Asthma After Hurricane Ike 3Health News:Growing Health Profession Could Unlock Key to a Healthier America 2Health News:Growing Health Profession Could Unlock Key to a Healthier America 3Health News:Growing Health Profession Could Unlock Key to a Healthier America 4
For the quantitative determination of total glucose in serum....
Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L). Single vial, dry powder reagent....
Inorganic phosphorus (UV method) reagent is for the quantitative determination of inorganic phosphorus in human serum....
For the quantitative determination of Inorganic Phosphorus in serum. Linearity: 12.0 mg/dl....
Medicine Products: